Dual SGLT1/SGLT2 Inhibitor Phlorizin Ameliorates Non-Alcoholic Fatty Liver Disease and Hepatic Glucose Production in Type 2 Diabetic Mice

por David-Silva, Aline, Esteves, João Victor, Morais, Mychel Raony P T, Freitas, Helayne Soares, Zorn, Telma Maria, Correa-Giannella, Maria Lucia, Machado, Ubiratan Fabres
Publicado 2020

Tumour‐derived transforming growth factor‐β signalling contributes to fibrosis in patients with cancer cachexia

por Lima, Joanna D.C.C., Simoes, Estefania, de Castro, Gabriela, Morais, Mychel Raony P.T., de Matos‐Neto, Emidio M., Alves, Michele J., Pinto, Nelson I., Figueredo, Raquel G., Zorn, Telma M.T., Felipe‐Silva, Aloísio S., Tokeshi, Flavio, Otoch, José P., Alcantara, Paulo, Cabral, Fernanda J., Ferro, Emer S., Laviano, Alessandro, Seelaender, Marilia
Publicado 2019